tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Global Medical REIT Reports Q3 2025 Net Loss

Story Highlights
Global Medical REIT Reports Q3 2025 Net Loss

TipRanks Black Friday Sale

Global Medical REIT ( (GMRE) ) has provided an update.

On November 4, 2025, Global Medical REIT Inc. reported a net loss of approximately $6.0 million for the third quarter of 2025, a significant decline from the net income of $1.8 million in the same period the previous year. The company’s portfolio, as of September 30, 2025, was 95.2% occupied, with a weighted average lease term of 5.3 years, indicating stable occupancy levels despite the financial loss, which could impact investor confidence and the company’s market positioning.

The most recent analyst rating on (GMRE) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Global Medical REIT stock, see the GMRE Stock Forecast page.

Spark’s Take on GMRE Stock

According to Spark, TipRanks’ AI Analyst, GMRE is a Neutral.

Global Medical REIT’s overall stock score is primarily impacted by financial performance challenges, including negative profitability and cash flow issues. While the earnings call provided some positive insights into debt management and NOI growth, the technical indicators suggest a bearish trend, and the valuation metrics highlight significant risks. The high dividend yield may appeal to some investors, but the underlying financial instability poses a considerable risk.

To see Spark’s full report on GMRE stock, click here.

More about Global Medical REIT

Global Medical REIT Inc. operates in the real estate investment trust (REIT) industry, focusing on acquiring and managing healthcare-related facilities. The company’s portfolio primarily consists of outpatient medical buildings, inpatient rehabilitation facilities, hospitals, and long-term acute care hospitals, with a significant emphasis on outpatient medical buildings.

Average Trading Volume: 198,557

Technical Sentiment Signal: Sell

Current Market Cap: $469M

See more data about GMRE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1